COMPOSITIONS AND METHODS FOR TREATMENT OF EXOCRINE PANCREATIC INSUFFICIENCY (EPI)
A method of treating exocrine pancreatic insufficiency includes administering to an individual in need thereof (e.g., an individual with cystic fibrosis) an effective amount of an enteral composition having a total protein consisting essentially of hydrolyzed protein and a total fat containing monoa...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French German |
Published |
28.07.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A method of treating exocrine pancreatic insufficiency includes administering to an individual in need thereof (e.g., an individual with cystic fibrosis) an effective amount of an enteral composition having a total protein consisting essentially of hydrolyzed protein and a total fat containing monoacylglycerols (MAG) that are at least about 30 wt. % of the total fat, and the total fat optionally further contains medium chain triglycerides (MCT) and/or fatty acids. In one particular non-limiting embodiment, about 60 wt. % of the total fat is from MCT and about 40 wt. % of the total fat is from MAG; in another particular non-limiting embodiment, the total fat is MAG with free fatty acids (esterified and/or bound) without MCT; and in yet another particular non-limiting embodiment, the total fat is MAG alone without MCT. |
---|---|
Bibliography: | Application Number: EP20190789864 |